HIV Medicine

Article	Citations
	120
Issue Information	88
	81
Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta‐analysis	64
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study	59
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy	48
User‐reported outcomes of long‐acting injectable PrEP with Cabotegravir: Real‐world experience from Milan	42
	42
Issue Information	40
Reflections on a specialist HIV menopause service	37
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	36
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	34
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	33
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	32
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	30
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	30
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	26
HIV cure: Are we going to make history?	25
HIV testing in primary care in a low‐prevalence area of Northeast England	24
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	24
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	24
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	21
	20
Issue Information	20
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	19

Issue Information	19
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	18
Using an automated decision support tool to improve HIV prescribing: A feasibility study	18
The value of herpes zoster prevention in people aging with HIV: A narrative review	18
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	17
Influence of physical activity on endothelial function in people living with HIV	16
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	15
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	15
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	15
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	15
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	15
Issue Information	15
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	15
Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV	15
Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy	15
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	14
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	14
Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort	14
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	14
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	14
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	14
	13
	13
	13
Issue Information	12
Gender equality in leadership of HIV care cascade clinical trials: A methodological study	12
Special issue on Women and HIV to mark International Women’s Day	12
Issue Information	12
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature	12
Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY	12
Temporal network analysis of comorbidities among people with HIV in South Carolina	11
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis	11
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	11
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	11
AI in medicine: No longer the future, but the present	11
Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study	11
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	11
	10
Oral Abstracts	10
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	10
The role of HIV as a risk modifier for coronary endothelial function in young adults	10
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individual	10
	10
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	10
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection	10
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	10
Microbial translocation is associated with advanced liver fibrosis among people with HIV	10
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	10
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	10
	10

Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	9
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	9
Index	9
Late diagnosis of human immunodeficiency virus (HIV) and its associated factors in Asian countries: A systematic review	9
Towards inclusive HIV cure development: Identifying important and acceptable HIV cure attributes a	9
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	8
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	8
Author Index	8
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection	8
Author Index	8
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature rev	8
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	8
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	8
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	8
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	8
Polypharmacy in HIV : Rethinking what counts and why it matters	8
Issue Information	8
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	7
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	7
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)	7
Anticholinergic medications associated with falls and frailty in people with HIV	7
Issue Information	7
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV	7
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	7
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	7
Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary HIV care centre in Gaborone, Botswana: A cross‐s	7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021	7
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	7
Sex differences in cardiovascular disease and associated factors in people living with HIV : Evidence from All of Us program	7
Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross‐sectional study based on the two‐continua model	7
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV	7
Immune response to ART initiation in advanced HIV infection	7
Late diagnosis of HIV: An updated consensus definition	7
Supporting long‐term engagement in HIV clinical care: Learning from the COVID ‐19 pandemic	7
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	7
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Sexual dysfunction care needs of gay, bisexual, and other men who have sex with men living with HIV in Montreal, Canada	6
	6
Issue Information	6
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
Issue Information	6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
CROI 2024 BHIVA working group summary	6
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	6
A cross‐sectional comparison of the use of frailty assessment tools in older people living with HIV	6
Issue Information	6
	6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
Issue Information	6
Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Issue Information	6
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
	6
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	6
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	6
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	5
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	5
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	5
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	5
	5
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study	5
Comorbidities, comedications and potential drug–drug interactions among people living with HIV in China	5
	5
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	5
Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi‐center survey in France (ANRS CO13 HEPAVIH)	5
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	5
Issue Information	5

Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
Issue Information	5
Issue Information	5
Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	5
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	5
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	5
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	5
Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation	5
Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
Risk factors, management, and HPV genotyping of vulvar intraepithelial neoplasia ( VIN ) in women	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
Natural occurrence of drug resistance mutations to the HIV ‐1 capsid inhibitor lenacapavir	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
EACS Abstract 2025	4
Issue Information	4
	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
Late diagnosis of HIV in 2022: Why so little change?	4
	4
	4
	4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish	4
	4
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach	4
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia	4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	4
PrEP for women in Europe: a systematic literature review	4
Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV	4
Erratum	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
	4
Issue Information	4
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025	4
	4
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (	4
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	4
Authors' Reply to Letter to the Editor Regarding ‘Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final	4
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria	4
HIV and fracture: Risk, assessment and intervention	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study	4
	4
Issue Information	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
The spectrum of kidney biopsy findings in Chinese HIV‐infected patients	4
People diagnosed with HIV before continuing care in England are extremely unlikely to pass on HIV in England	4